17.08.2013 Views

Opioids, Reward and Addiction: An Encounter of Biology ...

Opioids, Reward and Addiction: An Encounter of Biology ...

Opioids, Reward and Addiction: An Encounter of Biology ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>and</strong> naltrexone (2 mg/kg) suppressed responding below<br />

the levels seen after saline injections (Stewart <strong>and</strong> Wise,<br />

1992). Using this reinstatement procedure, the same<br />

research group replicated their findings, in that reexposure<br />

to heroin after abstinence reinstated heroin-seeking<br />

behavior, whereas an injection <strong>of</strong> naloxone did not<br />

(Shaham <strong>and</strong> Stewart, 1996; Shaham et al., 1996, 1997).<br />

Moreover, they found that brief exposure to footshock<br />

stress or corticotropin-releasing hormone reinstated<br />

heroin-seeking behavior, thereby mimicking the effect <strong>of</strong><br />

a noncontingent priming infusion <strong>of</strong> heroin, although<br />

differences may be present with regard to the neurobiology<br />

<strong>of</strong> the various reinstatement stimuli (Shaham <strong>and</strong><br />

Stewart, 1994, 1995; Shaham et al., 1996, 1997). By<br />

contrast, the aversive state <strong>of</strong> opioid withdrawal, induced<br />

by an injection with naltrexone, did not reinstate<br />

drug-seeking behavior. Other abused drugs like amphetamine<br />

<strong>and</strong> cocaine are also capable to reinstate drugseeking<br />

behavior in animals, previously trained to selfadminister<br />

heroin (De Wit <strong>and</strong> Stewart, 1983; De Vries<br />

et al., 1998). It has been argued that the reinstatement<br />

model is relevant for assessing opioid-induced relapse.<br />

In general, it seems that both the pure -opioid agonists<br />

(such as morphine, methadone, codeine, <strong>and</strong> heroin)<br />

<strong>and</strong> the mixed -opioid agonist-antagonists (such as<br />

butorphanol, nalbuphine, <strong>and</strong> buprenorphine) serve as<br />

positive reinforcers in the different i.v. self-administration<br />

paradigms in monkeys <strong>and</strong> rats. On the other h<strong>and</strong>,<br />

-opioid agonists (such as ethylketazocine, ketazocine,<br />

<strong>and</strong> benzomorphan lig<strong>and</strong>s) <strong>and</strong> opioid antagonists<br />

(such as levallorphan, naloxone, <strong>and</strong> naltrexone) do not<br />

maintain self-administration behavior or even maintain<br />

responses that postpone or terminate their injection<br />

(negative reinforcers). In the rat, however, self-administration<br />

<strong>of</strong> (ethyl)ketazocine <strong>and</strong> nalorphine has been<br />

reported.<br />

B. Variables Interfering with Opioid<br />

Self-Administration<br />

Drug-taking behavior in general, <strong>and</strong> opioid selfadministration<br />

in particular, is controlled by a number<br />

<strong>of</strong> variables. The most commonly discussed variables<br />

concern those that can readily be manipulated, e.g., the<br />

dose <strong>of</strong> the drug administered, the route <strong>of</strong> administration,<br />

the schedules <strong>of</strong> reinforcement, <strong>and</strong> the presence or<br />

absence <strong>of</strong> physical dependence, tolerance, <strong>and</strong> sensitization.<br />

In addition, a number <strong>of</strong> predisposing variables<br />

(e.g., preexposure to opioids during gestation, environmental<br />

factors, <strong>and</strong> genetic factors) can affect drugtaking<br />

behavior. The contribution <strong>of</strong> these factors will be<br />

discussed briefly. The discussion will focus on studies<br />

with rhesus monkeys <strong>and</strong> rats since the reinforcing<br />

properties <strong>of</strong> opioids have been studied most extensively<br />

in these species.<br />

1. Dose <strong>of</strong> the Drug. The dose <strong>of</strong> the drug per injection<br />

(“unit dose”) is an important <strong>and</strong> critical factor in drugtaking<br />

behavior. A linear function between the log dose<br />

OPIOIDS, REWARD AND ADDICTION 351<br />

<strong>of</strong> drug delivered per injection <strong>and</strong> the amount <strong>of</strong> drug<br />

taken (Fig. 1) has been shown to exist for various opioids<br />

in different species <strong>of</strong> animals (Weeks <strong>and</strong> Collins, 1964,<br />

1979; Smith et al., 1976; Harrigan <strong>and</strong> Downs, 1978a;<br />

Van Ree et al., 1978; Dai et al., 1989). Moreover, studying<br />

heroin self-administration, it was demonstrated that<br />

the linear relationship between the log unit dose <strong>and</strong><br />

drug intake is present during initial exposure to heroin<br />

<strong>and</strong> in animals physically dependent on heroin (Van Ree<br />

et al., 1978; Dai et al., 1989).<br />

<strong>An</strong> intermediate dose range is optimal for maintaining<br />

self-administration <strong>of</strong> morphine, whereas lower <strong>and</strong><br />

higher doses do not favor it. Data from a wide range <strong>of</strong><br />

unit doses for drug-naive rats taking i.v. morphine on a<br />

continuous schedule <strong>of</strong> reinforcement have been reported<br />

(Smith et al., 1976; Weeks <strong>and</strong> Collins, 1979). On<br />

the fifth or sixth day <strong>of</strong> self-administration, a medium<br />

dose <strong>of</strong> around 30 g/kg morphine per infusion maintained<br />

a maximum number <strong>of</strong> i.v. deliveries. When lower<br />

doses <strong>of</strong> morphine were tested, a progressive decrease in<br />

the rate <strong>of</strong> self-administration was found, probably due<br />

FIG. 1. Self-administration <strong>of</strong> morphine sulfate in rats. Presented are<br />

the mean number <strong>of</strong> self-infusions (A) <strong>and</strong> the mean amount <strong>of</strong> drug<br />

intake (B) by either the i.v. (F) or the intragastric route (E) versus the<br />

unit dose <strong>of</strong> morphine sulfate per infusion. Data from Smith et al. (1976).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!